As of 2025-09-16, the EV/EBITDA ratio of Regenxbio Inc (RGNX) is -2.55. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. RGNX's latest enterprise value is 379.58 mil USD. RGNX's TTM EBITDA according to its financial statements is -148.75 mil USD. Dividing these 2 quantities gives us the above RGNX EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 14.3x - 17.3x | 15.7x |
| Forward P/E multiples | 27.1x - 49.0x | 39.2x |
| Fair Price | (78.35) - (49.43) | (79.27) |
| Upside | -962.0% - -643.8% | -972.0% |
| Date | EV/EBITDA |
| 2025-09-16 | -2.62 |
| 2025-09-15 | -2.55 |
| 2025-09-12 | -2.59 |
| 2025-09-11 | -2.69 |
| 2025-09-10 | -2.71 |
| 2025-09-09 | -2.82 |
| 2025-09-08 | -2.68 |
| 2025-09-05 | -2.76 |
| 2025-09-04 | -2.66 |
| 2025-09-03 | -2.81 |
| 2025-09-02 | -2.56 |
| 2025-08-29 | -2.50 |
| 2025-08-28 | -2.52 |
| 2025-08-27 | -2.46 |
| 2025-08-26 | -2.56 |
| 2025-08-25 | -2.51 |
| 2025-08-22 | -2.52 |
| 2025-08-21 | -2.22 |
| 2025-08-20 | -2.21 |
| 2025-08-19 | -2.19 |
| 2025-08-18 | -2.42 |
| 2025-08-15 | -2.46 |
| 2025-08-14 | -2.54 |
| 2025-08-13 | -2.50 |
| 2025-08-12 | -2.22 |
| 2025-08-11 | -2.00 |
| 2025-08-08 | -2.13 |
| 2025-08-07 | -2.15 |
| 2025-08-06 | -2.26 |
| 2025-08-05 | -2.28 |
| 2025-08-04 | -2.29 |
| 2025-08-01 | -2.25 |
| 2025-07-31 | -2.35 |
| 2025-07-30 | -2.44 |
| 2025-07-29 | -2.32 |
| 2025-07-28 | -2.45 |
| 2025-07-25 | -2.51 |
| 2025-07-24 | -2.57 |
| 2025-07-23 | -2.55 |
| 2025-07-22 | -2.38 |
| 2025-07-21 | -2.35 |
| 2025-07-18 | -2.24 |
| 2025-07-17 | -2.42 |
| 2025-07-16 | -2.35 |
| 2025-07-15 | -2.26 |
| 2025-07-14 | -2.42 |
| 2025-07-11 | -2.41 |
| 2025-07-10 | -2.54 |
| 2025-07-09 | -2.58 |
| 2025-07-08 | -2.43 |